* Vicarious Surgical Inc RBOT.N RBOT.K is expected
to show no
change in quarterly revenue when it reports results on November
12 for the period ending September 30 2024
*
* LSEG's mean analyst estimate for Vicarious Surgical Inc
is for
a loss of $2.55 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Vicarious
Surgical Inc is $10.00, above its last closing price of $8.40.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -2.81 -2.77 -2.59 Beat 6.7
Mar. 31 2024 -2.81 -2.85 -3.00 Missed -5.3
Dec. 31 2023 -3.73 -3.75 -1.80 Beat 52
Sep. 30 2023 -3.95 -4.27 -3.00 Beat 29.8
Jun. -4.44 -4.27 -3.60 Beat 15.8
30 2023
Mar. 31 2023 -4.05 -4.05 -6.30 Missed -55.6
Dec. 31 2022 -5.40 -5.20 -2.70 Beat 48.1
Sep. 30 2022 -4.71 -4.65 -6.00 Missed -29
This summary was machine generated November 9 at 00:05 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)